A detailed history of Bearing Point Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Bearing Point Capital, LLC holds 46,649 shares of PFE stock, worth $1.15 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
46,649
Previous 52,140 10.53%
Holding current value
$1.15 Million
Previous $1.32 Billion 14.42%
% of portfolio
0.21%
Previous 0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

SELL
$21.59 - $24.84 $118,550 - $136,396
-5,491 Reduced 10.53%
46,649 $1.13 Billion
Q1 2025

May 07, 2025

BUY
$25.01 - $27.13 $67,276 - $72,979
2,690 Added 5.44%
52,140 $1.32 Billion
Q4 2024

Feb 14, 2025

BUY
$24.8 - $30.19 $1.23 Million - $1.49 Million
49,450 New
49,450 $1.31 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $138B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bearing Point Capital, LLC Portfolio

Follow Bearing Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bearing Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bearing Point Capital, LLC with notifications on news.